[cnbc 3000085063]
Human Genome Sciences rejected the $2.6 billion unsolicited takeover bid from GlaxoSmithKline, reports CNBC’s Herb Greenberg.
Melissa Lee anchors a fast-paced discussion among four professional Wall Street traders. An hour after the bell Fast Money hosts one of the best trading discussions of the day.
Video © and provided by CNBC.
Be the first to comment